OpenAI, Anthropic, DeepMind CEOs urge Congress for bioweapon safeguards
Three AI pioneers sign open letter demanding mandatory synthetic DNA screening.
Top AI executives from OpenAI, Anthropic, and Google DeepMind—Sam Altman, Dario Amodei, and Demis Hassabis respectively—have signed an open letter published in the Wall Street Journal urging Congress to mandate screening of synthetic nucleic acid orders. The letter argues that current voluntary guidelines are insufficient given rapid advances in AI that could lower barriers to designing dangerous pathogens. The CEOs warn that without mandatory checks, AI systems could be misused to generate sequences for bioweapons, making oversight critical.
The letter specifically calls for legislation requiring all DNA synthesis providers to screen orders against databases of known pathogen sequences and toxins before fulfilling them. This mirrors existing voluntary standards adopted by some companies, but the signatories stress that a legal mandate ensures universal compliance. The move comes as AI labs increasingly focus on biological capabilities, with recent studies showing models can assist in designing novel proteins. If enacted, the law would create a regulatory framework for DNA synthesis similar to export controls on dual-use biotechnologies, aiming to prevent catastrophic misuse.
- Ceos from OpenAI, Anthropic, and Google DeepMind jointly signed the open letter.
- The letter demands Congress mandate screening of synthetic nucleic acid orders, not just voluntary guidelines.
- Goal is to prevent AI-enabled design and production of biological weapons using synthetic DNA.
Why It Matters
Could set binding U.S. biosecurity rules for AI labs and DNA synthesis services.